Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shaw

Showing results (1291-1300 of 1,355) with videos related to

Pageof 136
Sort By:
Science Translational Medicine|June 13, 2014
Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosisYang Zhou, Hong Peng, Huanxing Sun, et al.
Gene Therapy|April 21, 2001
CL22 - a novel cationic peptide for efficient transfection of mammalian cellsA M Haines, A S Irvine, A Mountain, et al.
Oncogene|August 21, 2007
BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinomaB C-L Chan, A K-K Ching, K-F To, et al.
Plos Pathogens|September 27, 2017
Correction: Cathelicidin Insufficiency in Patients with Fatal LeptospirosisJanet C Lindow, Elsio A Wunder, Stephen J Popper, et al.
Plos Pathogens|November 5, 2016
Cathelicidin Insufficiency in Patients with Fatal LeptospirosisJanet C Lindow, Elsio A Wunder, Stephen J Popper, et al.
JCI Insight|January 17, 2020
Perfect timing: circadian rhythms, sleep, and immunity - an NIH workshop summaryJeffrey A Haspel, Ron Anafi, Marishka K Brown, et al.
Nature Neuroscience|August 6, 2013
Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formationDongyi Xu, Weiping Shen, Rong Guo, et al.
Nature|October 11, 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Chantal B F Vogels, Inci Yildirim, et al.
Nature|March 3, 2006
Mitoferrin is essential for erythroid iron assimilationGeorge C Shaw, John J Cope, Liangtao Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048Ethan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Pageof 136

Showing results (1291-1300 of 1,355) with videos related to

Sort By:
Pageof 136
Science Translational Medicine|June 13, 2014
Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosisYang Zhou, Hong Peng, Huanxing Sun, et al.
Gene Therapy|April 21, 2001
CL22 - a novel cationic peptide for efficient transfection of mammalian cellsA M Haines, A S Irvine, A Mountain, et al.
Oncogene|August 21, 2007
BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinomaB C-L Chan, A K-K Ching, K-F To, et al.
Plos Pathogens|September 27, 2017
Correction: Cathelicidin Insufficiency in Patients with Fatal LeptospirosisJanet C Lindow, Elsio A Wunder, Stephen J Popper, et al.
Plos Pathogens|November 5, 2016
Cathelicidin Insufficiency in Patients with Fatal LeptospirosisJanet C Lindow, Elsio A Wunder, Stephen J Popper, et al.
JCI Insight|January 17, 2020
Perfect timing: circadian rhythms, sleep, and immunity - an NIH workshop summaryJeffrey A Haspel, Ron Anafi, Marishka K Brown, et al.
Nature Neuroscience|August 6, 2013
Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formationDongyi Xu, Weiping Shen, Rong Guo, et al.
Nature|October 11, 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunityCarolina Lucas, Chantal B F Vogels, Inci Yildirim, et al.
Nature|March 3, 2006
Mitoferrin is essential for erythroid iron assimilationGeorge C Shaw, John J Cope, Liangtao Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048Ethan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Pageof 136